The use of poison on arrows marked a revolution in human hunting technology—new evidence suggests it happened tens of ...

Arrowhead Pharmaceuticals (ARWR) is back in focus after fresh regulatory approvals for REDEMPLO in China and Canada, along ...

Arrowhead Pharmaceuticals recently announced that Health Canada issued a Notice of Compliance for REDEMPLO (plozasiran) as an ...

As of Wednesday, January 07, Arrowhead Pharmaceuticals, Inc.’s ARWR share price has dipped by 7.85%, which has investors questioning if this is right time to buy.

In terms of liquidity and interest, the mean open interest for Arrowhead Pharma options trades today is 878.14 with a total volume of 5,476.00.

Travis Kelce could be mere weeks from retirement. The Chiefs legend spoke on the matter on the latest episode of the brothers ...

Shares of Arrowhead Pharmaceuticals rose after the company reported positive interim data from two Phase 1/2 trials for obesity treatments. The stock was up 17%, at $74.61, late Tuesday morning and ...

Archaeologists find earliest known use of poison-laced weapons by humans - Prehistoric humans had advanced planning abilities ...

Arrowhead Pharmaceuticals (ARWR) announced its public offerings, pricing $625M of 0.00% convertible senior notes due in 2032 and 3.1M shares of common stock at $64.50 per share. Instead of common ...

The Lake Country School Board will ask voters to approve a $3.2 million operational referendum. If it fails, the district ...

Detailed price information for Arrowhead Pharma (ARWR-Q) from The Globe and Mail including charting and trades.